Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.39B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1B |
| 3 |
Citigroup
C
|
+$332M |
| 4 |
Apple
AAPL
|
+$307M |
| 5 |
Oracle
ORCL
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$579M |
| 2 |
EA
Electronic Arts
EA
|
+$233M |
| 3 |
Keurig Dr Pepper
KDP
|
+$215M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$206M |
| 5 |
XL
XL Group Ltd.
XL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.09% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 9.65% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Vericel Corp
VCEL
$2.17B
| $4.17M | 0.01% |
294,947
-499,420
| -63% | -$5.86M |
|
1927
Vicor
VICR
$9.09B
| $4.17M | 0.01% |
+90,723
| New | +$4.99M |
|
|
NSTG
1928
DELISTED
NanoString Technologies, Inc.
NSTG
| $4.17M | 0.01% |
234,004
-541,061
| -70% | -$7.9M |
|
|
JNCE
1929
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.16M | 0.01% |
640,261
-38,916
| -6% | -$289K |
|
|
DSPG
1930
DELISTED
DSP Group Inc
DSPG
| $4.16M | 0.01% |
349,725
-67,757
| -16% | -$840K |
|
1931
Philips
PHG
$26.4B
| $4.16M | 0.01% |
117,647
-21,525
| -15% | -$736K |
|
|
PRNB
1932
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $4.15M | 0.01% |
+141,925
| New | +$4.01M |
|
|
FTR
1933
DELISTED
Frontier Communications Corp.
FTR
| $4.13M | 0.01% |
636,703
-187,133
| -23% | -$1.02M |
|
1934
CALL
Starbucks
SBUX
$124B
| $4.13M | 0.01% |
+72,600
| New | +$3.84M |
|
1935
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
| $4.12M | 0.01% |
52,743
+36,176
| +218% | +$2.83M |
|
|
TTOO
1936
DELISTED
T2 Biosystems, Inc
TTOO
| $4.12M | 0.01% |
111
-124
| -53% | -$4.08M |
|
1937
Sally Beauty Holdings
SBH
$1.55B
| $4.12M | 0.01% |
223,965
+180,854
| +420% | +$2.89M |
|
|
VIVO
1938
DELISTED
Meridian Bioscience Inc
VIVO
| $4.11M | 0.01% |
276,023
-167,745
| -38% | -$2.6M |
|
|
GOOD
1939
Gladstone Commercial Corp
GOOD
$630M
| $4.11M | 0.01% |
214,553
+27,506
| +15% | +$541K |
|
|
IRBT
1940
DELISTED
iRobot
IRBT
| $4.11M | 0.01% |
37,381
+28,781
| +335% | +$2.71M |
|
1941
Saic
SAIC
$5.39B
| $4.1M | 0.01% |
50,853
-1,635
| -3% | -$139K |
|
1942
Moog Inc Class A
MOG.A
$12.2B
| $4.1M | 0.01% |
47,642
-181,251
| -79% | -$14.3M |
|
|
PGTI
1943
DELISTED
PGT, Inc.
PGTI
| $4.09M | 0.01% |
189,414
-465,002
| -71% | -$10.9M |
|
1944
Hercules Capital
HTGC
$3.3B
| $4.09M | 0.01% |
310,761
-192,627
| -38% | -$2.57M |
|
1945
Kornit Digital
KRNT
$727M
| $4.08M | 0.01% |
186,073
+167,945
| +926% | +$3.29M |
|
|
TKKSU
1946
DELISTED
TKK Symphony Acquisition Corporation Unit
TKKSU
| $4.04M | 0.01% |
+400,000
| New | +$4.03M |
|
1947
Financial Institutions
FISI
$804M
| $4.04M | ﹤0.01% |
128,608
-19,690
| -13% | -$637K |
|
1948
CytomX Therapeutics
CTMX
$723M
| $4.02M | ﹤0.01% |
217,491
-47,430
| -18% | -$1.08M |
|
1949
Cavco Industries
CVCO
$4.44B
| $4.02M | ﹤0.01% |
15,903
-60,810
| -79% | -$14.1M |
|
1950
Harmonic Inc
HLIT
$1.36B
| $4M | ﹤0.01% |
728,094
-875,261
| -55% | -$4.37M |
|
Similar funds
Israel Englander's Q3 2018 Portfolio in Review
As of Q3 2018, Israel Englander held 4,590 positions worth $81.6B, up 6.4% from $76.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander's Q3 2018 filing shows 841 new, 1,291 increased, 1,638 reduced and 748 closed positions. Its largest new stake was Fortive: 27,116,929 shares worth $1.44B. The largest sale was Altaba Inc, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q3 2018 buy was Fortive: 27,116,929 shares worth $1.44B.
- Israel Englander added most to Andeavor in Q3 2018, an estimated $1B increase.
- Israel Englander's biggest Q3 2018 reduction was Altaba Inc, cutting an estimated $579M.
- Israel Englander fully exited XL Group Ltd. in Q3 2018, selling an estimated $190M.
- Israel Englander's ten largest holdings make up 10% of its $81.6B portfolio in Q3 2018.
- Israel Englander opened 841 new positions and closed 748 in Q3 2018.
- Israel Englander's portfolio value rose 6.4% quarter-over-quarter to $81.6B.
Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.